SASSI, LORENZA
 Distribuzione geografica
Continente #
NA - Nord America 658
EU - Europa 322
AS - Asia 88
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.073
Nazione #
US - Stati Uniti d'America 656
IT - Italia 175
UA - Ucraina 50
SE - Svezia 37
CN - Cina 28
TR - Turchia 24
VN - Vietnam 23
DE - Germania 19
IE - Irlanda 19
SG - Singapore 13
FI - Finlandia 9
GB - Regno Unito 6
CL - Cile 3
RU - Federazione Russa 3
CA - Canada 2
AT - Austria 1
ES - Italia 1
EU - Europa 1
FR - Francia 1
GR - Grecia 1
PE - Perù 1
Totale 1.073
Città #
Milan 130
Fairfield 104
Woodbridge 61
Ashburn 58
Houston 55
Chandler 51
Seattle 47
Wilmington 47
Jacksonville 41
Cambridge 33
Nyköping 22
Dearborn 20
Dublin 19
Princeton 16
Izmir 13
Singapore 13
Boardman 12
Ann Arbor 10
San Diego 8
Dong Ket 6
New York 6
Como 5
Falls Church 5
Redmond 5
Washington 5
Kunming 4
Ogden 4
Rome 4
Cormano 3
Frankfurt am Main 3
Changchun 2
Chengdu 2
Chicago 2
Dallas 2
Fiano Romano 2
Hefei 2
London 2
Munich 2
Opera 2
Santa Clara 2
Aigaleo 1
Beachwood 1
Beijing 1
Berlin 1
Changsha 1
Conshohocken 1
Düsseldorf 1
East Brunswick 1
Hebei 1
Helsinki 1
Hounslow 1
La Canada Flintridge 1
Lima 1
Los Angeles 1
Mountain View 1
Nanjing 1
Ningbo 1
Ottawa 1
San Mateo 1
Shanghai 1
Shaoxing 1
Shenyang 1
Tappahannock 1
Toronto 1
Verona 1
Vienna 1
Wuhan 1
Xian 1
Zhoukou 1
Totale 859
Nome #
Masked hypertension in newly diagnosed hypothyroidism: a pilot study 179
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study 154
Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis 146
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 144
Thyroid hormone treatment for differentiated thyroid carcinoma: What drug, how long, what dose? 134
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center 133
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy 129
Quale trattamento attuare per l’ipertiroidismo nei pazienti con orbitopatia basedowiana? 46
DIAGNOSI E TRATTAMENTO DELLA TIREOTOSSICOSI INDOTTA DA AMIODARONE (AIT): DIFFERENZE ED ANALOGIE TRA AMERICAN THYROID ASSOCIATION (ATA) ED EUROPEAN THYROID ASSOCIATION (ETA) 19
Totale 1.084
Categoria #
all - tutte 4.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020146 0 0 0 0 0 30 35 30 20 15 4 12
2020/2021156 3 13 18 13 7 13 3 17 19 12 14 24
2021/202299 10 10 1 2 10 9 3 7 14 20 5 8
2022/2023138 14 19 12 12 8 32 0 17 13 4 3 4
2023/2024228 35 35 32 42 42 23 0 6 5 4 2 2
2024/202549 0 2 21 9 8 9 0 0 0 0 0 0
Totale 1.084